Media coverage of PrEPVacc's December 2023 study update
Following the announcement by PrEPVacc investigators that the vaccine trial in PrEPVacc has stopped further vaccinations, several organisations made statements, and media outlets covered the news, including the following:
Wednesday 6 December
STAT: ‘Last roll of the dice’ for a near-term HIV vaccine fails
POZ: Last Large HIV Vaccine Trial Halted
Erasing 76 Crimes: Hope for HIV vaccine falters as Africa-led project ends vaccine trial
NTV Uganda: Researchers: No vaccine efficacy registered in HIV vaccine trial
Monitor: HIV vaccine trial in Uganda stopped over ineffectiveness in preventing infection
IAVI: IAVI statement on PrEPVacc trial
HVTN: A statement from the HVTN on the PrEPVacc study announcement
IAS: IAS calls for stepping up HIV vaccine R&D after PrEPVacc halts its vaccine arm
AVAC: The Search for an HIV Vaccine Must Continue
Thursday 7 December
Guardian: HIV vaccine trial in Africa halted after disappointing initial results
Reuters: HIV vaccine trial in Africa halted after disappointing data
MedPage Today: 'End of This Phase': Trial Halts Testing of HIV Vaccine Candidates
Friday 8 December
Daily Monitor: HIV vaccine trial hits snag
allAfrica: Africa's First HIV Vaccine Trial Fails
O Globo: Última esperança de vacina para o HIV nesta década falha nos testes clínicos
Saturday 9 December
CNN: HIV vaccine trial dubbed ‘last roll of the dice’ halted over poor results
Wednesday 13 December
Bay Area Reporter: Last large HIV vaccine trial fails
Medical Channel Asia: PrEPVacc Halts HIV Vaccine Trial Amid Ineffectiveness
Thursday 14 December
The Body: HIV Is Not Over: Interview With Sharon Lewin, M.D., President of the International AIDS Society